EdgarLookup
8-K XBRL

8-K

Company
Kiniksa Pharmaceuticals International, plc
Filed
January 14, 2026
Period of Report
January 10, 2026
Accession Number
0001730430-26-000010

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →